エピジェネティック市場：動向、機会、競合分析【2023-2028年】

エピジェネティック市場の動向と予測

世界のエピジェネティック市場は、2023年から2028年までのCAGRが14.5%で、2028年までに推定36億米ドルに達すると予測されています。この市場の主な促進要因は、投資、資金調達、承認の増加によるエピジェネティック研究開発への取り組みの強化、創薬開発の推進におけるエピジェネティクスの応用の拡大、手頃な価格とアクセスしやすさによるゲノムシーケンスへのアクセスの拡大です。世界のエピジェネティック市場の将来は、学術・研究機関、製薬会社、バイオテクノロジー企業、委託研究機関（CRO）におけるビジネスチャンスで有望視されています。

エピジェネティック市場の洞察

• Lucintel社は、使いやすく、費用対効果が高く、先進的なエピジェネティックキットや試薬に対する需要が世界中で高まっていることから、キット＆試薬が予測期間中最大のセグメントであり続けると予測しています。
• この市場内では、政府研究機関や大学研究室でのエピジェネティック製品の広範な採用により、学術・研究機関が最大のエンドユースセグメントであり続けるでしょう。
• 北米は、先進医療インフラに対する意識の高まり、研究開発費の増加、同地域の大手企業の存在により、予測期間中最大の地域であり続けるでしょう。

本レポートでは、以下の11の主要な質問に回答しています：

• Q.1.市場セグメントのうち、最も有望かつ高成長な機会は何か？
• Q.2.どのセグメントがより速いペースで成長するのか、またその理由は？
• Q.3.今後成長が加速すると思われる地域とその理由は？
• Q.4.市場力学に影響を与える主な要因は何か？市場における主な課題とビジネスリスクは？
• Q.5.この市場におけるビジネスリスクと競合の脅威は？
• Q.6.この市場における新たな動向とその理由は？
• Q.7.市場における顧客の需要の変化にはどのようなものがありますか？
• Q.8.この市場における新たな開発と、その開発をリードしている企業は？
• Q.9.この市場における主要企業は？主要企業は事業成長のためにどのような戦略的取り組みを進めているのか？
• Q.10.この市場における競合製品にはどのようなものがあり、材料や製品の代替による市場シェア低下の脅威はどの程度ありますか？
• Q.11.過去5年間にどのようなM&Aが行われ、業界にどのような影響を与えましたか？

目次

第1章 エグゼクティブサマリー

第2章 世界のエピジェネティック市場：市場力学

• イントロダクション、背景、分類
• サプライチェーン
• 業界の促進要因と課題

第3章 2017年から2028年までの市場動向と予測分析

• マクロ経済動向（2017～2022年）と予測（2023～2028年）
• 世界のエピジェネティック市場動向（2017-2022）と予測（2023-2028）
• 製品およびサービス別の世界のエピジェネティック市場
  • キットと試薬
  • 酵素
  • 楽器と付属品
  • ソフトウェア
  • サービス
• 技術別の世界のエピジェネティック市場
  • DNAメチル化
  • ヒストンのメチル化
  • その他
• 最終用途産業別の世界のエピジェネティック市場
  • 学術調査機関
  • 製薬会社とバイオテクノロジー企業
  • 受託調査機関（CRO）
  • その他

第4章 2017年から2028年までの地域別の市場動向と予測分析

• 地域別の世界のエピジェネティック市場
• 北米のエピジェネティック市場
• 欧州のエピジェネティック市場
• アジア太平洋エピジェネティック市場
• その他地域エピジェネティック市場

第5章 競合の分析

• 製品ポートフォリオ分析
• 運用上の統合
• ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

• 成長機会分析
  • 製品およびサービス別の世界エピジェネティック市場の成長機会
  • テクノロジーによる世界のエピジェネティック市場の成長機会
  • 最終用途産業別の世界のエピジェネティック市場の成長機会
  • 地域別の世界のエピジェネティック市場の成長機会
• 世界のエピジェネティック市場における新たな動向
• 戦略的分析
  • 新製品の開発
  • 世界のエピジェネティック市場の能力拡大
  • 世界のエピジェネティック市場における合併、買収、合弁事業
  • 認証とライセンシング

第7章 有力企業の企業プロファイル

• Abcam
• Active Motiff
• Hologic
• F. Hoffmann-La Roche
• Illumina
• Qiagen
• Thermo Fisher Scientific
• Novartis
• Element Biosciences
• Dovetail Genomics

Epigenetic Market Trends and Forecast

The future of the global epigenetic market looks promising with opportunities in the academic and research institutes, pharmaceutical companies and biotechnology companies, and contract research organizations (CROs). The global epigenetic market is expected to reach an estimated $3.6 billion by 2028 with a CAGR of 14.5% from 2023 to 2028. The major drivers for this market are enhanced commitment to epigenetic research and development through increased investment, funding, and approvals, growing application of epigenetics in advancing drug discovery and development, and broadening access to genome sequencing owing to its affordability and accessibility.

A more than 150-page report is developed to help in your business decisions.

Epigenetic Market by Segment

The study includes trends and forecast for the global epigenetic market by product & service, technology, end use industry, and region as follows:

Epigenetic Market by Product & Service [Shipment Analysis by Value from 2017 to 2028]:

• Kits & Reagents
• Enzymes
• Instruments & Accessories
• Software
• Services

Epigenetic Market by Technology [Shipment Analysis by Value from 2017 to 2028]:

• DNA Methylation
• Histone Methylation
• Others

Epigenetic Market by End Use Industry [Shipment Analysis by Value from 2017 to 2028]:

• Academic and Research Institutes
• Pharmaceutical Companies and Biotechnology Companies
• Contract Research Organizations (CROs)
• Others

Epigenetic Market by Region [Shipment Analysis by Value from 2017 to 2028]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Epigenetic Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies, epigenetic companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the epigenetic companies profiled in this report include:

• Abcam
• Active Motiff
• Hologic
• F. Hoffmann-La Roche
• Illumina
• Qiagen
• Thermo Fisher Scientific
• Novartis
• Element Biosciences
• Dovetail Genomics

Epigenetic Market Insights

• Lucintel forecasts that kits & reagents will remain the largest segment over the forecast period due to growing demand for simple-to-use, cost-effective, and advanced epigenetic kits and reagents across the globe.
• Within this market, academics and research institutes will remain the largest end use segment due to the widespread adoption of epigenetic products across government research institutions and university laboratories.
• North America will remain the largest region over the forecast period due to increasing awareness of advanced medical infrastructure, growing R&D expenditures, and the existence of major companies in this region.

Features of the Global Epigenetic Market

• Market Size Estimates: Epigenetic market size estimation in terms of value ($B).
• Trend and Forecast Analysis: Market trends (2017 to 2022) and forecast (2023 to 2028) by various segments and regions.
• Segmentation Analysis: Epigenetic market size by various segments, such as by product & service, technology, end use industry, and region in terms of value ($B).
• Regional Analysis: Epigenetic market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
• Growth Opportunities: Analysis of growth opportunities in different products & services, technologies, end use industries, and regions for the epigenetic market.
• Strategic Analysis: This includes M&A, new product development, and competitive landscape of the Epigenetic Market.
• Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

• Q.1. What is the epigenetic market size?
• Answer: The global epigenetic market is expected to reach an estimated $3.6 billion by 2028.
• Q.2. What is the growth forecast for epigenetic market?
• Answer: The global epigenetic market is expected to grow with a CAGR of 14.5% from 2023 to 2028
• Q.3. What are the major drivers influencing the growth of the epigenetic market?
• Answer: The major drivers for this market are enhanced commitment to epigenetic research and development through increased investment, funding, and approvals, growing application of epigenetics in advancing drug discovery and development, and broadening access to genome sequencing owing to its affordability and accessibility.
• Q4. What are the major segments for epigenetic market?
• Answer: The future of the global epigenetic market looks promising with opportunities in academic and research institutes, pharmaceutical and biotechnology companies, and contract research organizations (CROs).
• Q5. Who are the key epigenetic companies?
• Answer: Some of the key epigenetic companies are as follows:
  • Abcam
  • Active Motiff
  • Hologic
  • F. Hoffmann-La Roche
  • Illumina
  • Qiagen
  • Thermo Fisher Scientific
  • Novartis
  • Element Biosciences
  • Dovetail Genomics
• Q6. Which epigenetic market segment will be the largest in future?
• Answer: Lucintel forecasts that kits & reagents will remain the largest segment over the forecast period due to growing demand for simple-to-use, cost-effective, and advanced epigenetic kits and reagents across the globe.
• Q7. In epigenetic market, which region is expected to be the largest in next 5 years?
• Answer: North America will remain the largest region over the forecast period due to increasing awareness of advanced medical infrastructure, growing R&D expenditures and the existence of major companies in this region.
• Q.8. Do we receive customization in this report?
• Answer: Yes, Lucintel provides 10% Customization Without any Additional Cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the global epigenetic market by product & service (kits & reagents, enzymes, instruments & accessories, software, and services), technology (DNA methylation, histone methylation, and others), end use industry (academic and research institutes, pharmaceutical companies and biotechnology companies, contract research organizations (CROs), and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last five years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Epigenetic Market: Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2017 to 2028

• 3.1: Macroeconomic Trends (2017-2022) and Forecast (2023-2028)
• 3.2: Global Epigenetic Market Trends (2017-2022) and Forecast (2023-2028)
• 3.3: Global Epigenetic Market by Product & Service
  • 3.3.1: Kits & Reagents
  • 3.3.2: Enzymes
  • 3.3.3: Instruments & Accessories
  • 3.3.4: Software
  • 3.3.5: Services
• 3.4: Global Epigenetic Market by Technology
  • 3.4.1: DNA Methylation
  • 3.4.2: Histone Methylation
  • 3.4.3: Others
• 3.5: Global Epigenetic Market by End Use Industry
  • 3.5.1: Academic and Research Institutes
  • 3.5.2: Pharmaceutical Companies and Biotechnology Companies
  • 3.5.3: Contract Research Organizations (CROs)
  • 3.5.4: Others

4. Market Trends and Forecast Analysis by Region from 2017 to 2028

• 4.1: Global Epigenetic Market by Region
• 4.2: North American Epigenetic Market
  • 4.2.1: North American Epigenetic Market by Product & Service: Kits & Reagents, Enzymes, Instruments & Accessories, Software, and Services
  • 4.2.2: North American Epigenetic Market by End Use Industry: Academic and Research Institutes, Pharmaceutical Companies and Biotechnology Companies, Contract Research Organizations (CROs), and Others
• 4.3: European Epigenetic Market
  • 4.3.1: European Epigenetic Market by Product & Service: Kits & Reagents, Enzymes, Instruments & Accessories, Software, and Services
  • 4.3.2: European Epigenetic Market by End Use Industry: Academic and Research Institutes, Pharmaceutical Companies and Biotechnology Companies, Contract Research Organizations (CROs), and Others
• 4.4: APAC Epigenetic Market
  • 4.4.1: APAC Epigenetic Market by Product & Service: Kits & Reagents, Enzymes, Instruments & Accessories, Software, and Services
  • 4.4.2: APAC Epigenetic Market by End Use Industry: Academic and Research Institutes, Pharmaceutical Companies and Biotechnology Companies, Contract Research Organizations (CROs), and Others
• 4.5: ROW Epigenetic Market
  • 4.5.1: ROW Epigenetic Market by Product & Service: Kits & Reagents, Enzymes, Instruments & Accessories, Software, and Services
  • 4.5.2: ROW Epigenetic Market by End Use Industry: Academic and Research Institutes, Pharmaceutical Companies and Biotechnology Companies, Contract Research Organizations (CROs), and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Epigenetic Market by Product & Service
  • 6.1.2: Growth Opportunities for the Global Epigenetic Market by Technology
  • 6.1.3: Growth Opportunities for the Global Epigenetic Market by End Use Industry
  • 6.1.4: Growth Opportunities for the Global Epigenetic Market by Region
• 6.2: Emerging Trends in the Global Epigenetic Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Epigenetic Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Epigenetic Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Abcam
• 7.2: Active Motiff
• 7.3: Hologic
• 7.4: F. Hoffmann-La Roche
• 7.5: Illumina
• 7.6: Qiagen
• 7.7: Thermo Fisher Scientific
• 7.8: Novartis
• 7.9: Element Biosciences
• 7.10: Dovetail Genomics